Opaleye Management Inc. 的 Form 4 申報
Tracon Pharmaceuticals, Inc.（TCON），2021/12/29 申報
- 申報編號
- 0001493152-21-032688
- 申報時間
- 2021/12/29
- 交易日
- 2021/12/27-12/28
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 4 筆非衍生性交易。公開市場買進合計 $30.8 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/12/27 | Common Stock, par value $0.001 per share | P買進取得 | +75,000 | $2.92F3 | +$219,000 | 2,592,371 | 間接 | |
| 2021/12/27 | Common Stock, par value $0.001 per share | P買進取得 | +12,325 | $2.92F3 | +$35,989 | 265,000 | 間接 | |
| 2021/12/28 | Common Stock, par value $0.001 per share | P買進取得 | +125.3 | $2.63F4 | +$329.54 | 2,717,675 | 間接 | |
| 2021/12/28 | Common Stock, par value $0.001 per share | P買進取得 | +20,000 | $2.63F4 | +$52,600 | 285,000 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.9213. The range of purchase prices on the transaction date was $2.86 to $2.99 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 2 筆交易的價格引用這則附註。
- F4
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.631. The range of purchase prices on the transaction date was $2.49 to $2.83 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
表 I 有 2 筆交易的價格引用這則附註。